Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency
Authors:
- 1 May 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (9) , 1311-1316
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Nonpeptide oxytocin antagonists: Potent, orally bioavailable analogs of L-371,257 containing A 1-R-(pyridyl)ethyl ether terminusBioorganic & Medicinal Chemistry Letters, 1998
- Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related PyridinesJournal of Medicinal Chemistry, 1998
- Small molecule ligands for oxytocin and vasopressin receptorsMedicinal Research Reviews, 1997
- Regioselective nucleophilic substitutions of fluorobenzene derivativesTetrahedron Letters, 1996
- Recent Advances in the Development of Oxytocin Receptor AntagonistsCurrent Pharmaceutical Design, 1996
- 1-[1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2- methoxybenzoyl]piperidin-4-yl]-4H-3,1- benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.Journal of Medicinal Chemistry, 1995
- Characterization of the human oxytocin receptor stably expressed in 293 human embryonic kidney cellsLife Sciences, 1995
- 1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo[2.2.1]heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine (L-368,899): An Orally Bioavailable, Non-Peptide Oxytocin Antagonist with Potential Utility for Managing Preterm LaborJournal of Medicinal Chemistry, 1994
- L‐368,899, a potent orally active oxytocin antagonist for potential use in preterm laborDrug Development Research, 1993
- Thallium in organic synthesis. XXXIII. One-step synthesis of methyl arylacetates from acetophenones using thallium(III) nitrate (TTN)Journal of the American Chemical Society, 1973